Rebecca Jolley has been appointed senior vice president and commercial head of Oncology at Bayer, and Dr. Scott Z. Fields was named senior vice president and pharmaceutical development head, Oncology. Both are members of the Oncology Leadership Team and report to Robert LaCaze, executive vice president and head of the Oncology Strategic Business Unit. “It is important that we stay focused on the science coupled with speed and agility to help bring important new medications and indicatio...